Timber Pharmaceuticals Price Prediction

TMBRDelisted Stock  USD 1.72  0.01  0.58%   
As of today, The value of RSI of Timber Pharmaceuticals' share price is at 54. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Timber Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

54

 
Oversold
 
Overbought
The successful prediction of Timber Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Timber Pharmaceuticals and does not consider all of the tangible or intangible factors available from Timber Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Timber Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using Timber Pharmaceuticals hype-based prediction, you can estimate the value of Timber Pharmaceuticals from the perspective of Timber Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Timber Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Timber because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Timber Pharmaceuticals after-hype prediction price

    
  USD 1.72  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Intrinsic
Valuation
LowRealHigh
1.531.531.89
Details
Naive
Forecast
LowNextHigh
1.631.631.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.581.812.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Timber Pharmaceuticals. Your research has to be compared to or analyzed against Timber Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Timber Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Timber Pharmaceuticals.

Timber Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Timber Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Timber Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Timber Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Timber Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Timber Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Timber Pharmaceuticals' historical news coverage. Timber Pharmaceuticals' after-hype downside and upside margins for the prediction period are 1.72 and 1.72, respectively. We have considered Timber Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.72
1.72
After-hype Price
1.72
Upside
Timber Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Timber Pharmaceuticals is based on 3 months time horizon.

Timber Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Timber Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Timber Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Timber Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
1 Events / Month
11 Events / Month
Very soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.72
1.72
0.00 
0.00  
Notes

Timber Pharmaceuticals Hype Timeline

Timber Pharmaceuticals is at this time traded for 1.72. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Timber is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Timber Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 1.72. The company recorded a loss per share of 1.97. Timber Pharmaceuticals last dividend was issued on the 19th of May 2020. The entity had 1:50 split on the 9th of November 2022. Given the investment horizon of 90 days the next forecasted press release will be very soon.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Timber Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Timber Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Timber Pharmaceuticals' future price movements. Getting to know how Timber Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Timber Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SLRXSalarius Pharmaceuticals(0.17)3 per month 0.00 (0.05) 9.59 (9.15) 27.43 
ARTLWArtelo Biosciences 0.00 0 per month 23.45  0.08  68.38 (41.25) 147.53 
NTRBNutriband(0.83)4 per month 5.70 (0.01) 11.41 (8.78) 33.94 
ALRNAileron Therapeutics(0.13)5 per month 4.69  0.02  8.06 (7.99) 41.47 
ARTLArtelo Biosciences(0.01)5 per month 0.00 (0.04) 7.83 (7.75) 26.32 
HSTOHistogen 0.00 0 per month 0.00 (0.12) 4.76 (4.55) 131.40 
CRISCuris Inc(0.20)7 per month 0.00 (0.20) 6.11 (4.98) 15.31 
FWBIFirst Wave BioPharma 0.00 0 per month 0.00 (0.23) 8.65 (14.74) 65.42 
SABSSAB Biotherapeutics 0.08 11 per month 6.51  0.05  17.06 (11.25) 45.73 
VCNXVaccinex 0.61 6 per month 0.00 (0.04) 11.11 (14.00) 54.95 
GOVXGeoVax Labs 0.02 6 per month 0.00 (0.08) 9.26 (11.63) 77.95 
TCONTRACON Pharmaceuticals(0.01)8 per month 0.00 (0.18) 19.59 (17.77) 52.05 
ENTXEntera Bio(0.03)4 per month 3.08 (0.02) 5.47 (5.47) 29.16 
TPSTTempest Therapeutics(0.09)4 per month 0.00 (0.13) 6.38 (8.53) 29.55 
BTTXBetter Therapeutics(0.33)62 per month 0.00 (0.14) 12.64 (9.62) 36.53 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 
SNTISenti Biosciences(0.03)2 per month 0.00 (0.1) 7.04 (7.36) 29.17 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 
QNRXQuoin Pharmaceuticals Ltd(0.03)9 per month 6.79  0.03  17.65 (9.68) 74.46 

Timber Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Timber price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Timber using various technical indicators. When you analyze Timber charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Timber Pharmaceuticals Predictive Indicators

The successful prediction of Timber Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Timber Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Timber Pharmaceuticals based on analysis of Timber Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Timber Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Timber Pharmaceuticals's related companies.

Story Coverage note for Timber Pharmaceuticals

The number of cover stories for Timber Pharmaceuticals depends on current market conditions and Timber Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Timber Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Timber Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Timber Pharmaceuticals Short Properties

Timber Pharmaceuticals' future price predictability will typically decrease when Timber Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Timber Pharmaceuticals often depends not only on the future outlook of the potential Timber Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Timber Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.1 M
Cash And Short Term Investments9.1 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Timber Stock

If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance